Sub Banner Image

Hims Won’t Back Down From Selling Weight-Loss Shots

Markets

·

June 25, 2025

·

Bloomberg

Hims & Hers Health CEO Andrew Dudum said the company will continue to sell cheap weight-loss shots despite Novo Nordisk A/S ending their distribution partnership over “deceptive marketing” practices. Sam Fazeli has more on “Bloomberg Open Interest.”

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.